
Bona Law, a national boutique antitrust law firm headquartered in San Diego, announced on Tuesday, April 6, that two prominent antitrust attorneys, Pat Pascarella and Jim Lerner, have joined the firm.
Together they bring with them more than five decades of experience at top international law firms and a dozen years as chief in-house antitrust counsel at a Fortune 10 company.
“Pat’s background-as a partner in a Global Competition Review 100 antitrust practice, as a government enforcer, and as in-house antitrust counsel, coupled with his in-depth knowledge of the antitrust laws-makes him a unique asset to our clients,” said Jarod Bona, CEO of Bona Law. “We are excited that he has agreed to join us.”
Jim Lerner joins Bona Law from Winston & Strawn. Jim has three decades of experience as a global antitrust counselor and litigator and has represented clients before regulatory and enforcement agencies in numerous high-profile US and international criminal and civil cartel investigations, including those in the EU, Japan, Canada, Mexico, Brazil, Taiwan, and Korea, and involving products such as lysine, food flavor enhancers (MSG and nucleotides), carbon fiber, impact modifiers and processing aids, vitamins, cathode ray tubes, computer components, and automobile parts. He also has defended numerous clients in major multi-jurisdiction antitrust class actions.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas